Neurocrine Clinical Site

Lemon Grove, California 91945

2 studies enrolling now · 7 studies all time

What they study most

Anhedonia, Major Depressive Disorder, Schizophrenia, Tardive Dyskinesia (TD)

Studies at this site

• Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia — Recruiting now
• NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia — Recruiting now
• A Study to Evaluate the Efficacy and Safety of NBI-1070770 in Adults With Major Depressive Disorder — Completed
• Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia — Completed
• Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-1117568 in Adults With Schizophrenia — Completed
• Study to Evaluate the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDD — Completed
• Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia — Completed